Avelumab (anti-PD-L1)Avelumab (anti-PD-L1)
Move your mouse over image or click to enlarge

Avelumab (anti-PD-L1)

Avelumab (anti-PD-L1) (Bavencio, MSB0010718C) is a fully human IgG1 monoclonal antibody that targets the protein programmed death-ligand 1 (PD-L1). Avelumab exhibits potential antibody-dependent cell-mediated cytotoxicity and is used for the treatment of several kinds of carcinoma. MW=143.8 kDa.
Cat# Size Price Qty Buy
A2015-5mg 5mg £900.00

Additional Information

Property Value or Rating
Product Size 5mg
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2015

Related Documents